BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 26684800)

  • 1. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
    Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
    Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells.
    Shi Z; Wu D; Tang R; Li X; Chen R; Xue S; Zhang C; Sun X
    J Biosci; 2016 Jun; 41(2):229-36. PubMed ID: 27240983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells.
    Xia YY; Yin L; Jiang N; Guo WJ; Tian H; Jiang XS; Wu J; Chen M; Wu JZ; He X
    Biochem Biophys Res Commun; 2015 Jul; 463(3):357-63. PubMed ID: 26025649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
    Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
    Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical role of HMGA2 in regulation of EMT in epithelial ovarian carcinomas.
    Yan J; Zhang Y; Shi W; Ren C; Liu Y; Pan Y
    Tumour Biol; 2016 Jan; 37(1):823-8. PubMed ID: 26250458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p/HMGA2 axis.
    Li WJ; Li G; Liu ZW; Chen ZY; Pu R
    Neoplasma; 2021 Nov; 68(6):1225-1235. PubMed ID: 34641698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Glucose Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in A20 Murine Diffuse Large B-Cell Lymphoma Cells Through Increased Expression of High Mobility Group AT-Hook 2 (HMGA2).
    Wang Y; Tan J; Wu H; Yi C
    Med Sci Monit; 2019 May; 25():3860-3868. PubMed ID: 31124542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Let-7a suppresses glioma cell proliferation and invasion through TGF-β/Smad3 signaling pathway by targeting HMGA2.
    Li Y; Zhang X; Chen D; Ma C
    Tumour Biol; 2016 Jun; 37(6):8107-19. PubMed ID: 26715270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
    Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
    J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
    Kou B; Liu W; Tang X; Kou Q
    Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [miR-let-7c-5p inhibits invasion and migration of bladder cancer cells by targeting HMGA2].
    Yao Y; Zhang C; Xiong Y; Han B; Gao X; Wang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1022-1029. PubMed ID: 34308851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGA2 promotes the migration and invasion of gallbladder cancer cells and HMGA2 knockdown inhibits angiogenesis via targeting VEGFA.
    Yan J; Dai P; Qin X; He Y; Zhang Y
    Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
    Lee J; Ha S; Jung CK; Lee HH
    Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
    Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
    J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
    Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
    Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
    Cai J; Shen G; Liu S; Meng Q
    Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGA2 is associated with the aggressiveness of tongue squamous cell carcinoma.
    Zhang H; Tang Z; Deng C; He Y; Wu F; Liu O; Hu C
    Oral Dis; 2017 Mar; 23(2):255-264. PubMed ID: 27809392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGA2 Modulates the TGFβ/Smad, TGFβ/ERK and Notch Signaling Pathways in Human Lens Epithelial-Mesenchymal Transition.
    Hou M; Bao X; Luo F; Chen X; Liu L; Wu M
    Curr Mol Med; 2018; 18(2):71-82. PubMed ID: 29974827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway.
    Yang J; Fan L; Liao X; Cui G; Hu H
    Bioengineered; 2021 Dec; 12(2):9377-9389. PubMed ID: 34818994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
    Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.